As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing-sometimes in as few as 10 healthy people-can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the...

This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of technology. Montana's plan to become an experimental medical hub just pushed forward As of this week in Montana, biotech companies whose drugs have been through preliminary testing-sometimes in as few as 10...